Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort

• Päätekijät: Tangui Barré (Tekijä), Fabrice Carrat (Tekijä), Clémence Ramier (Tekijä), Hélène Fontaine (Tekijä), Vincent Di Beo (Tekijä), Morgane Bureau (Tekijä), Céline Dorival (Tekijä), Dominique Larrey (Tekijä), Elisabeth Delarocque-Astagneau (Tekijä), Philippe Mathurin (Tekijä), Fabienne Marcellin (Tekijä), Ventzislava Petrov-Sanchez (Tekijä), Carole Cagnot (Tekijä), Patrizia Carrieri (Tekijä), Stanislas Pol (Tekijä), Camelia Protopopescu (Tekijä), the ANRS/AFEF Hepather study group (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: BMC, 2022-06-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Abstract Background Patients with chronic hepatitis C virus (HCV) infection are at greater risk of developing metabolic disorders. Obesity is a major risk factor for these disorders, and therefore, managing body weight is crucial. Cannabis use, which is common in these patients, has been associated...